Rolapitant

Introduction: What is Rolapitant?

Rolapitant is a medication primarily used to prevent nausea and vomiting associated with chemotherapy. It belongs to a class of drugs known as neurokinin1 (NK1) receptor antagonists. By blocking certain signals in the brain, Rolapitant helps manage the side effects of cancer treatments, improving the quality of life for patients undergoing chemotherapy.

Uses of Rolapitant

Rolapitant is approved for use in adults to prevent both acute and delayed nausea and vomiting caused by highly emetogenic chemotherapy. It is approved specifically for delayed nausea/vomiting following initial/moderately emetogenic chemotherapy (HEC/MEC), used with other antiemetics (e.g., dexamethasone ? 5-HT3 antagonist). Acute coverage is adjunctive, not primary. The drug is particularly beneficial for patients receiving cisplatin-based chemotherapy, which is known for its high potential to induce nausea and vomiting.

How Does It Work?

Rolapitant works by blocking the action of substance P, a neuropeptide that plays a key role in vomiting reflex. By inhibiting the neurokinin1 receptors in the brain, Rolapitant reduces the signals that trigger nausea and vomiting. This mechanism helps patients feel more comfortable during and after their chemotherapy sessions.

Dosage and Administration

The standard adult dosage of Rolapitant is a single oral dose of 180 mg, taken within 2 hours prior to the start of chemotherapy. Rolapitant is available in tablet form and should be swallowed whole with water. It is not recommended to chew or crush the tablets.

Side Effects of Rolapitant

Common side effects of Rolapitant may include:

• Fatigue
• Dizziness
• Diarrhea
• Decreased appetite

Serious side effects, although less common, can include:

• Allergic reactions (rash, itching, swelling)
• Severe dizziness or fainting
• QT prolongation
• Infusion-related reactions (for IV form)
• Liver problems (rare; indicated by yellowing of the skin or eyes; post-marketing reports)

Patients should report any unusual or severe side effects to their healthcare provider immediately.

Drug Interactions

Rolapitant can interact with several medications, which may affect how it works or increases the risk of side effects. Major drug interactions include:

• CYP2D6 substrates (e.g., thioridazine, pimozide) - contraindicated due to QT prolongation risk
• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) - increase rolapitant exposure (monitor)
• Strong CYP3A4 inducers (e.g., rifampin, St. John's Wort) - decrease rolapitant exposure (avoid if possible)
• Other antiemetics (e.g., ondansetron, granisetron) - generally not significant but noted for combo use

It is crucial to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

Benefits of Rolapitant

The primary benefit of Rolapitant is its effectiveness in preventing nausea and vomiting associated with chemotherapy, particularly in patients receiving highly emetogenic regimens. By improving control over these side effects, Rolapitant can enhance a patient's overall treatment experience, allowing them to maintain better nutrition and hydration, and ultimately improving their quality of life during cancer treatment.

Contraindications of Rolapitant

Rolapitant should be avoided in certain populations, including:

• Pregnant or breastfeeding women (not assigned pregnancy category; animal data suggest risk) - avoidance recommended.
• Known hypersensitivity to rolapitant or excipients.
• Patients with severe hepatic impairment (Child-Pugh C): Reduce dose to 90 mg.

Always consult a healthcare provider to determine if Rolapitant is appropriate for your specific health condition.

Precautions and Warnings

Before starting Rolapitant, patients should undergo a thorough medical evaluation. Special precautions may include:

• Monitoring liver function, especially in patients with preexisting liver conditions.
• Assess potential drug interactions with current medications.
• Discuss any history of allergic reactions to medications.
• Regular follow-up appointments may be necessary to monitor the patient's response to treatment and adjust dosages as needed.

FAQs

1. What is Rolapitant used for? Rolapitant is used to prevent nausea and vomiting caused by chemotherapy, particularly in patients receiving highly emetogenic regimens.
2. How is Rolapitant taken? It is taken as a single oral tablet, usually one hour before chemotherapy.
3. What are the common side effects? Common side effects include fatigue, dizziness, diarrhea, and decreased appetite.
4. Can I take Rolapitant with other medications? You should inform your healthcare provider about all medications you are taking, as Rolapitant can interact with several drugs.
5. Is Rolapitant safe during pregnancy? Its safety during pregnancy has not been established, so it should be avoided unless prescribed by a doctor.
6. How does Rolapitant work? It blocks neurokinin1 receptors in the brain, reducing signals that trigger nausea and vomiting.
7. What should I do if I miss a dose? Do not take if close to chemotherapy start; consult provider?it's a single-dose regimen, not daily.
8. Can children take Rolapitant? Pediatric dosing varies, so consult a healthcare provider for appropriate dosage for children.
9. What should I do if I experience severe side effects? Contact your healthcare provider immediately if you experience severe side effects or allergic reactions.
10. How long does Rolapitant last? The effects of Rolapitant can last for several days (half-life ~169-183 hours), primarily targeting delayed phase (up to 72 hours post-chemo).

Brand Names

Rolapitant is marketed under the brand name Varubi. It is available in tablet form for oral administration.

Conclusion

Rolapitant is a valuable medication for patients undergoing chemotherapy, effectively preventing nausea and vomiting associated with treatment. Its unique mechanism of action and ability to improve the quality of life for cancer patients make it an essential part of supportive care in oncology. Always consult with a healthcare provider to determine if Rolapitant is the right choice for your treatment plan.